Multiple roles of socs proteins: Differential expression of socs1 and socs3 in atherosclerosis

International Journal of Molecular Medicine

Volumn 31, Issue 5, 2013, Pages 1066-1074

  Liang, Xiao ^a   He, Ming ^a   Chen, Tao ^a   Liu, Yan ^a   Tian, Yu Ling ^a   Wu, Yu Liang ^a   Zhao, Yan ^a   Shen, Yan ^a   Yuan, Zu Yi ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Atherosclerosis; Cholesterol; Inflammation; Macrophage; Suppressors of cytokine signalling

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; INTERLEUKIN 6; SUPPRESSOR OF CYTOKINE SIGNALING 1; SUPPRESSOR OF CYTOKINE SIGNALING 3;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROTIC PLAQUE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; ISCHEMIC HEART DISEASE; LIPID DIET; LIPID STORAGE; MALE; MONONUCLEAR CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; ANIMALS; AORTA; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CHOLESTEROL; CORONARY DISEASE; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; FEEDING BEHAVIOR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKOCYTES, MONONUCLEAR; LIPID METABOLISM; MALE; MICE; MICE, INBRED C57BL; MIDDLE AGED; STAINING AND LABELING; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TIME FACTORS; UP-REGULATION;

EID: 84876110578     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2013.1323     Document Type: Article

References (36)

1. Ross R: Atherosclerosis-an inflammatory disease. N Engl J Med 340: 115-126, 1999.
2. Tedgui A and Mallat Z: Cytokines in atherosclerosis: Pathogenic and regulatory pathways. Physiol Rev 86: 515-581, 2006.
3. Ortiz-Munoz G, Martin-Ventura JL, Hernandez-Vargas P, et al: Suppressors of cytokine signaling modulate JAK/STAT-mediated cell responses during atherosclerosis. Arterioscler Thromb Vasc Biol 29: 525-531, 2009.
4. Yan C, Cao J, Wu M, et al: Suppressor of cytokine signaling 3 inhibits LPS-induced IL-6 expression in osteoblasts by suppressing CCAAT/enhancer-binding protein {beta} activity. J Biol Chem 285: 37227-37239, 2010.
5. Albanesi C, Fairchild HR, Madonna S, et al: IL-4 and IL-13 negatively regulate TNF-alpha-and IFN-gamma-induced beta-defensin expression through STAT-6, suppressor of cytokine signaling (SOCS)-1, and SOCS-3. J Immunol 179: 984-992, 2007.
6. Alexander WS and Hilton DJ: The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response. Annu Rev Immunol 22: 503-529, 2004.
7. Yoshimura A, Naka T and Kubo M: SOCS proteins, cytokine signalling and immune regulation. Nat Rev Immunol 7: 454-465, 2007.
8. Davey GM, Heath WR and Starr R: SOCS1: A potent and multifaceted regulator of cytokines and cell-mediated inflammation. Tissue Antigens 67: 1-9, 2006.
9. Egan PJ, Lawlor KE, Alexander WS and Wicks IP: Suppressor of cytokine signaling-1 regulates acute inflammatory arthritis and T cell activation. J Clin Invest 111: 915-924, 2003.
10. Metcalf D, Di Rago L, Mifsud S, et al: The development of fatal myocarditis and polymyositis in mice heterozygous for IFN-gamma and lacking the SOCS-1 gene. Proc Natl Acad Sci USA 97: 9174-9179, 2000.
11. Ilangumaran S, Ramanathan S and Rottapel R: Regulation of the immune system by SOCS family adaptor proteins. Semin Immunol 16: 351-365, 2004.
12. Jo D, Liu D, Yao S, et al: Intracellular protein therapy with SOCS3 inhibits inflammation and apoptosis. Nat Med 11: 892-898, 2005.
13. Li Y, Chu N, Rostami A and Zhang GX: Dendritic cells transduced with SOCS-3 exhibit a tolerogenic/DC2 phenotype that directs type 2 Th cell differentiation in vitro and in vivo. J Immunol 177: 1679-1688, 2006.
14. Matsumura Y, Kobayashi T, Ichiyama K, et al: Selective expansion of foxp3-positive regulatory T cells and immunosuppression by suppressors of cytokine signaling 3-deficient dendritic cells. J Immunol 179: 2170-2179, 2007.
15. Liu Y, Stewart KN, Bishop E, et al: Unique expression of suppressor of cytokine signaling 3 is essential for classical macrophage activation in rodents in vitro and in vivo. J Immunol 180: 6270-6278, 2008.
16. O'Keefe GM, Nguyen VT, Ping Tang LL and Benveniste EN: IFN-gamma regulation of class II transactivator promoter IV in macrophages and microglia: Involvement of the suppressors of cytokine signaling-1 protein. J Immunol 166: 2260-2269, 2001.
17. Croker BA, Krebs DL, Zhang JG, et al: SOCS3 negatively regulates IL-6 signaling in vivo. Nat Immunol 4: 540-545, 2003.
18. Yoshimura A, Suzuki M, Sakaguchi R, et al: SOCS, inflammation, and autoimmunity. Front Immunol 3: 20, 2012.
19. Wormald S and Hilton DJ: Inhibitors of cytokine signal transduction. J Biol Chem 279: 821-824, 2004.
20. Brown MS and Goldstein JL: Lipoprotein metabolism in the macrophage: Implications for cholesterol deposition in atherosclerosis. Annu Rev Biochem 52: 223-261, 1983.
21. Gower RM, Wu H, Foster GA, et al: CD11c/CD18 expression is upregulated on blood monocytes during hypertriglyceridemia and enhances adhesion to vascular cell adhesion molecule-1. Arterioscler Thromb Vasc Biol 31: 160-166, 2011.
22. Gokalp D, Tuzcu A, Bahceci M, et al: Levels of proinflammatory cytokines and hs-CRP in patients with homozygous familial hypercholesterolaemia. Acta Cardiol 64: 603-609, 2009.
23. Sima AV, Stancu CS and Simionescu M: Vascular endothelium in atherosclerosis. Cell Tissue Res 335: 191-203, 2009.
24. Steinberg D: Atherogenesis in perspective: Hypercholesterolemia and inflammation as partners in crime. Nat Med 8: 1211-1217, 2002.
25. Tian Y, Yuan Z, Liu Y, et al: Pioglitazone modulates the balance of effector and regulatory T cells in apolipoprotein E deficient mice. Nutr Metab Cardiovasc Dis 21: 25-32, 2011.
26. Anderson JL, Adams CD, Antman EM, et al: ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol 50: E1-e157, 2007.
27. Zhao Y, Yuan Z, Liu Y, et al: Activation of cannabinoid CB2 receptor ameliorates atherosclerosis associated with suppression of adhesion molecules. J Cardiovasc Pharmacol 55: 292-298, 2010.
28. Xue JH, Yuan Z, Wu Y, et al: High glucose promotes intracellular lipid accumulation in vascular smooth muscle cells by impairing cholesterol influx and efflux balance. Cardiovasc Res 86: 141-150, 2010.
29. He L, He M, Lv X, et al: NF-kappaB binding activity and pro-inflammatory cytokines expression correlate with body mass index but not glycosylated hemoglobin in Chinese population. Diabetes Res Clin Pract 90: 73-80, 2010.
30. Tang J, Kozaki K, Farr AG, et al: The absence of platelet-derived growth factor-B in circulating cells promotes immune and inflammatory responses in atherosclerosis-prone ApoE-/-mice. Am J Pathol 167: 901-912, 2005.
31. Endo TA, Masuhara M, Yokouchi M, et al: A new protein containing an SH2 domain that inhibits JAK kinases. Nature 387: 921-924, 1997.
32. Park SJ, Oh EJ, Yoo MA and Lee SH: Involvement of DNA-dependent protein kinase in regulation of stress-induced JNK activation. DNA Cell Biol 20: 637-645, 2001.
33. Kinjyo I, Hanada T, Inagaki-Ohara K, et al: SOCS1/JAB is a negative regulator of LPS-induced macrophage activation. Immunity 17: 583-591, 2002.
34. Libby P, Ridker PM and Hansson GK: Inflammation in atherosclerosis: From pathophysiology to practice. J Am Coll Cardiol 54: 2129-2138, 2009.
35. Li Y, Schwabe RF, DeVries-Seimon T, et al: Free cholesterol-loaded macrophages are an abundant source of tumor necrosis factor-alpha and interleukin-6: Model of NF-kappaB-and map kinase-dependent inflammation in advanced atherosclerosis. J Biol Chem 280: 21763-21772, 2005.
36. Frisdal E, Lesnik P, Olivier M, et al: Interleukin-6 protects human macrophages from cellular cholesterol accumulation and attenuates the proinflammatory response. J Biol Chem 286: 30926-30936, 2011.